Combined spatial frequency spectroscopy analysis with visible resonance Raman for optical biopsy of human brain metastases of lung cancers

Yan Zhou; Cheng-Hui Liu; Yang Pu; Binlin Wu; Thien An; Gangge Cheng; Lixin Zhou; Ke Zhu; Jun Chen; Qingbo Li; Robert R.

doi:10.1142/s179354581950010x

[1] “Quick brain tumor facts”, National Brain Tumor Society, http://braintumor.org/brain-tumor-information/brain-tumor-facts/.

[2] A. Jemal et al., “Cancer statistics, 2004,” CA Cancer J. Clin. 54, 8–29 (2004).

[3] W. D. Travis, J. Linder, B. Mackay, Classification, histology, cytology, and electron microscopy, Lung Cancer: Principles and Practice, H. I. Passet al., Eds., 2nd Edition, pp. 453–495, Lippincott Williams & Wilkins, Philadelphia (2000).

[4] R. F. DeVore III, D. H. Johnson, Chemotherapy for small cell lung cancer, Lung Cancer: Principles and Practice, H. I. Passet al., Eds., 2nd Edition, pp. 923–939. Lippincott Williams & Wilkins, Philadelphia (2000).

[5] M. H. T. Reinges, H.-H. Nguyen, T. Krings, B.-O. Hütter, V. Rohde, J. M. Gilsbach, “Course of brain shift during microsurgical resection of supratentorial cerebral lesions: Limits of conventional neuronavigation,” Acta Neurochir. (Wien) 146, 369–377 (2004). https://doi.org/10.1007/s00701-003-0204-1

[6] I. J. Gerard, M. Kersten-Oertel, K. Petrecca, D. Sirhan, J. A. Hall, D. L. Collins, “Brain shift in neuronavigation of brain tumors: A review,” Med. Image Anal. 35, 403–420 (2017).

[7] R. R. Alfano et al., “Laser induced fluorescence spectro scopy from native cancerous and normal tissue,” IEEE J. Quantum Electron. 20, 1507–1511 (1984).

[8] R. R. Alfano et al., “Human breast tissues studied by IR Fourier transform Raman spectroscopy,” Lasers Life Sci. 4, 23–28 (1991).

[9] C.-H. Liu et al., “Raman, fluorescence, and time-resolved light scattering as optical diagnostic techniques to separate diseased and normal biomedical media,” J. Photochem. Photobiol. B 16(2), 187–209 (1992).

[10] Y. Zhou et al., “Human brain cancer studied by resonance Raman spectroscopy,” J. Biomed. Opt. 17, 116021 (2012).

[11] M. Jermyn, K. Mok, J. Mercier, J. Desroches, J. Pichette, K. Saint-Arnaud, L. Bernstein, M. C. Guiot, K. Petrecca, F. Leblond, “Intraoperative brain cancer detection with Raman spectroscopy in humans,” Sci. Transl. Med. 7, 274ra219 (2015).

[12] M. Ji et al., “Rapid, label-free detection of brain tumors with stimulated Raman scattering microscopy,” Sci. Transl. Med. 5, 201ra119 (2013).

[13] A. Imiela, B. Polis, L. Polis, H. Abramczyk, “Novel strategies of Raman imaging for brain tumor research,” Oncotarget 8, 85290–85310 (2017).

[14] Y. Zhou et al., “Optical pathology of human brain metastasis of lung cancer using combined resonance Raman and spatial frequency spectroscopies,” Proc. SPIE 9703, 97031R-1-6 (2016).

[15] J. Desroches, M. Jermyn, K. Mok, C. Lemieux-Leduc, J. Mercier, K. St-Arnaud, K. Urmey, M.-C. Guiot, E. Marple, K. Petrecca, F. Leblond, “Characterization of a Raman spectroscopy probe system for intraoperative brain tissue classification,” Biomed. Opt. Express 6, 2380–2397 (2015).

[16] M. F. Kircher, A. de la Zerda, J. V. Jokerst, C. L. Zavalet, P. J. Kempen, E. Mittr, K. Pitter, R. Huang, C. Campos, F. Habte, R. Sinclair, C. W. Brennan, I. K. Mellinghoff, E. C. Holland, S. S. Gambhir, “A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle,” Nat. Med. 18(5), 829 (2012).

[17] C.-H. Liu et al., “Resonance Raman and Raman spectroscopy for breast cancer detection,” Technol. Cancer Res. Treat. 12, 371–382 (2013).

[18] Y. Zhou et al., “Brain metastasis detection by resonant Raman optical biopsy method,” Proc. SPIE 8940, 89400C (2014).

[19] C.-H. Liu, B. Wu, L. Sordillo, S. Boydston-White, V. Sriramoju, C. Zhang, H. Beckman, L. Zhang, Z. Pei, L. Shi, R. R. Alfano, “A pilot study for distinguishing basal cell carcinoma from normal human skin tissues using resonance Raman spectroscopy,” J. Cancer Metastasis Treat. 5, 4 (2019).

[20] Y. Zhou, C.-H. Liu, B. Wu, C. Zhang, X. Yu, G. Cheng, H. Chen, Q. Liang, M. Zhang, K. Zhu, R. R. Alfano, “Invited article: Molecular biomarkers characterization for human brain glioma grading using visible resonance Raman spectroscopy,” APL Photonics 3, 120802 (2018).

[21] C.-H. Liu et al., “Vulnerable atherosclerotic plaque detection by resonance Raman spectroscopy,” J. Biomed. Opt. 21, 127006 (2016).

[22] K. Lin, W. Zheng, C. M. Lim, Z. Huang, “Real-time In vivo diagnosis of nasopharyngeal carcinoma using rapid fiber-optic raman spectroscopy,” Theranostics 7, 3517–3526 (2017).

[23] A. Mizuno, H. Kitajima, K. Kawauchi, S. Muraishi, Y. J. Ozaki, “Near infrared Fourier transform Raman spectroscopic study of human brain tissues and tumours,” J. Raman Spectrosc. 25, 25–29 (1994).

[24] S. Koljenovic et al., “Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by raman spectroscopy,” Lab. Invest. 82(10), 1265 (2002).

[25] C. Krafft, S. B. Sobottka, G. Schackert, R. Salzer, “Near infrared Raman spectroscopic mapping of native brain tissue and intracranial tumors,” Analyst 130, 1070–1077 (2005).

[26] R. Pandey, S. K. Paidi, J. W. Kang, N. Spegazzini, Discerning the differential molecular pathology of proliferative middle ear lesions using Raman spectroscopy, Sci. Rep. 5, 13305 (2015).

[27] B. Bodanese, L. J. Silveira, R. Albertini, R. A. Zangaro, M. T. T. Pacheco, “Differentiating normal and basal cell carcinoma human skin tissues in vitro using dispersive Raman spectroscopy: A comparison between principal components analysis and simplified biochemical models,” Photomed. Laser Surg. 28(Suppl 1), S119–S127 (2010).

[28] Y. Pu, J. Jagtap, A. Pradhan, R. R. Alfano, “Optical quantitative pathology of cervical intraepithelial neoplasia in human tissues using spatial frequency analysis,” J. Biophotonics 8(3), 233–238 (2015).

[29] S. Russell, T. A. Nguyen, C. R. Torres, S. Bhagroo, M. J. Russell, R. R. Alfano, “Spatial frequency analysis of high-density lipoprotein and iron-oxide nanoparticle transmission electron microscope image structure for pattern recognition in heterogeneous fields,” J. Biomed. Opt. 19(1), 15004 (2014). https://doi.org/10.1117/1.JBO.19.1.015004

[30] Y. Pu, J. Jagtap, A. Pradhan, R. R. Alfano, “Spatial frequency analysis for detecting early stage of cancer in human cervical tissues,” Technol. Cancer Res. Treat. 13(5), 421–425 (2014).

[31] J. Goodman, Introduction to Fourier Optics, 3rd Edition, Roberts & Company, Greenwood Village (2005).

[32] SEER ICD-O-3 Coding Materials Archive, Available at http://www.cancer.gov/cancertopics/factsheet/detection/staging/.

[33] T. Tanaka, M. Shnimizu, H. Moriwaki, “Cancer chemoprevention by carotenoids,” Molecules 17(3), 3202–3242 (2012).

[34] I. V. Ermakov, M. Sharifzadeh, M. Ermakov, W. Gellermann, “Resonance Raman detection of carotenoid antioxidants in living human tissue,” J. Biomed. Opt. 10, 064028 (2005).

[35] M. E. Darvin, W. Sterry, J. Lademann, T. Vergou, “The role of carotenoids in human skin,” Molecules 16, 10491 (2011).

[36] S. F. Haag et al., “Determination of the antioxidative capacity of the skin in vivo using resonance Raman and electron paramagnetic resonance spectroscopy,” Exp. Dermatol. 20, 483–487 (2011).

[37] J. Lademann, M. C. Meinke, W. Sterry, M. E. Darvin, “Carotenoids in human skin,” Exp. Dermatol. 20, 377–382 (2011).

[38] M. Wrona, W. Korytowski, M. Rozanowska, T. Sarna, T. G. Truscott, “Cooperation of antioxidants in protection against photosensitized oxidation,” Free Radic. Biol. Med. 35, 1319–1329 (2003).

[39] P. Palozza, N. I. Krinsky, “Beta-Carotene and alpha-tocopherol are synergistic antioxidants,” Arch. Biochem. Biophys. 297, 184–187 (1992).

[40] M. E. Darvin, W. Sterry, J. Lademann, “Resonance Raman spectroscopy as an effective tool for the determination of antioxidative stability of cosmetic formulations,” J. Biophotonics 3, 82–88 (2010).

[41] G. J. Puppels et al., “Development and application of Raman microspectroscopic and Raman imaging techniques for cell biological studies,” J. Mol. Struct. 347, 477–484 (1995).

[42] G. C. Prendergast, “Why tumours eat tryptophan,” Nature 478, 192–194 (2011).

[43] P. E. Hanninen, E. Soini, S. W. Hell, “Continuous wave excitation two-photon fluorescence microscopy,” J. Microsc. 176, 222–225 (1994).

[44] S. T. Mayne et al., “Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies,” Arch. Biochem. Biophys. 539(1), 1–18 (2013).

[45] I. V. Ermakov et al., “Skin carotenoids as biomarker for vegetable and fruit intake: Validation of the reflection-spectroscopy based “Veggie Meter”,” FASEB J. 30(1_supplement), 409.3 (2016).

[46] H. Ren, J. D. Biggs, S. Mukamel, “Two-dimensional stimulated ultraviolet resonance Raman spectra of tyrosine and tryptophan: A simulation study,” J. Raman Spectrosc. 44, 544–559 (2013).

[47] E. B. J. Wilson, “The normal modes and frequencies of vibration of the regular plane hexagon model of the benzene molecule,” Phys. Rev. 45, 706 (1934).

[48] R. P. Rava, T. G. Spiro, “Resonance enhancement in the ultraviolet Raman spectra of aromatic amino acids,” J. Phys. Chem. 89, 1856–1861 (1985).

[49] R. P. Rava, T. G. Spiro, “Selective enhancement of tyrosine and tryptophan resonance Raman spectra via ultraviolet laser excitation,” J. Am. Chem. Soc. 106, 4062–4064 (1984).

[50] C. A. Opitz et al., “An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor,” Nature 478, 197–203 (2011).

[51] F. Moroni, “Tryptophan metabolism and brain function: Focus on kynurenine and other indole metabolites,” Eur. J. Pharmacol. 375, 87–100 (1999).

[52] E. W. Yue et al., “INCB24360 (Epacadostat), a highly potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor for Immuno-oncology,” ACS Med. Chem. Lett. 8, 486–491 (2017).

[53] R. Campanella, “Membrane lipids modifications in human gliomas of different degree of malignancy,” J. Neurosurg. Sci. 36, 11–25 (1992).

[54] P. P. Sordillo, L. A. Sordillol, L. Helson, “The kynurenine pathway: A primary resistance mechanism in patients with glioblastoma,” Anticancer Res. 37, 2159–2171 (2017). https://doi.org/10.21873/anticanres.11551

[55] B. Hoffman et al., Williams Gynecology, 2nd Edition, McGraw-Hill Professional, New York (2012).

[56] D. F. Gleason, G. T. Mellinger, “Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging,” J. Urol. 111, 58–64 (1974).

[57] H. J. G. Bloom, W. W. Richardson, “Histological grading and prognosis in breast cancer: A study of 1409 cases of which 359 have been followed for 15 years,” Br. J. Cancer 11(3), 359–377 (1957).

[58] N. Efford, Digital Image Processing: A Practical Introduction Using JavaTM, Pearson Education, Addison-Wesley, Harlow, England (2000).

[59] C. Cortes, V. N. Vapnik, “Support-vector networks,” Mach. Learn. 20, 273–297 (1995).

[60] Y. Sun, Y. Pu, Y. Yang, R. R. Alfano, “Biomarkers spectral subspace for cancer detection,” J. Biomed. Opt. 17(10), 107005-1–107005-9 (2012).

[61] X. Y. Xu, Z. Z. Liu, Q. F. Wu, “A novel K-nearest neighbor classification algorithm based on maximum entropy,” Int. J. Adv. Comput. Technol. 5(5), (2013).

[62] Y. Zhou et al., “Resonance Raman Spectroscopy of human brain metastasis of lung cancer analyzed by blind source separation,” Proc. SPIE 10051, 100511I-1-7 (2017).

[63] Y. Zhou, C.-H. Liu, K. Zhu, B. Wu, X. Yu, R. R. Alfano, “Visible resonance Raman spectroscopy in human brain tissues, ” Neurophotonics and Biomedical Spectroscopy, R. R. AlfanoL. Shi, Eds., pp. 65–106.